3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials

Published on 2020-06-012022-10-05
Journal: Pharmacological research

[키워드] 3CLpro clinical trial Evidence inhibitor therapeutic option

[저자] Mekonnen Sisay

[Category] SARS, 임상,

[DOI] 10.1016/j.phrs.2020.104779

[Article Type] Correspondence

[Source] Sciencedirect

All Keywords
【제목키워드】 clinical trial, 3CLpro, inhibitor, Evidence, therapeutic option,